PET/MRI scan

DIAGNOSTIC_TEST2 trials

Sponsors

Kyoto University, Stanford University

Conditions

Healthy SubjectHealthy volunteer, Alzheimer&#39Pancreatic Carcinoma

Early Phase 1

Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers

CompletedNCT02683824

Stanford UniversityHealthy Subject, Pancreatic Carcinoma

Start: 2016-01-12End: 2022-12-01Updated: 2023-09-21

Unknown Phase

Research for Amyloid PET-MRI

Active, not recruitingJPRN-UMIN000040338

Kyoto UniversityHealthy volunteer, Alzheimer&#39

Start: 2020-06-01Target: 160Updated: 2026-06-29

Related Papers

Pilot-phase PET/CT study targeting integrin α<sub>v</sub>β<sub>6</sub> in pancreatic cancer patients using the cystine-knot peptide-based <sup>18</sup>F-FP-R<sub>0</sub>1-MG-F2.

2021-11-0312 citations